85 related articles for article (PubMed ID: 20357828)
1. IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.
Buff SM; Yu H; McCall JN; Caldwell SM; Ferkol TW; Flotte TR; Virella-Lowell IL
Gene Ther; 2010 May; 17(5):567-76. PubMed ID: 20357828
[TBL] [Abstract][Full Text] [Related]
2. Administration of nonviral gene vector encoding rat beta-defensin-2 ameliorates chronic Pseudomonas aeruginosa lung infection in rats.
Hu Q; Zuo P; Shao B; Yang S; Xu G; Lan F; Lu X; Xiong W; Xu Y; Xiong S
J Gene Med; 2010 Mar; 12(3):276-86. PubMed ID: 20131335
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice.
Yoshioka T; Okada T; Maeda Y; Ikeda U; Shimpo M; Nomoto T; Takeuchi K; Nonaka-Sarukawa M; Ito T; Takahashi M; Matsushita T; Mizukami H; Hanazono Y; Kume A; Ookawara S; Kawano M; Ishibashi S; Shimada K; Ozawa K
Gene Ther; 2004 Dec; 11(24):1772-9. PubMed ID: 15496963
[TBL] [Abstract][Full Text] [Related]
4. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
[TBL] [Abstract][Full Text] [Related]
5. Effects of bronchopulmonary inflammation induced by pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice.
van Heeckeren A; Ferkol T; Tosi M
Gene Ther; 1998 Mar; 5(3):345-51. PubMed ID: 9614554
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
7. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection.
Song Z; Moser C; Wu H; Faber V; Kharazmi A; Høiby N
J Cyst Fibros; 2003 Sep; 2(3):112-9. PubMed ID: 15463859
[TBL] [Abstract][Full Text] [Related]
8. Oral instillation with surfactant phospholipid: a reliable alternative to intratracheal injection in mouse studies.
Yu H; Buff SM; Baatz JE; Virella-Lowell I
Lab Anim; 2008 Jul; 42(3):294-304. PubMed ID: 18625584
[TBL] [Abstract][Full Text] [Related]
9. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
[TBL] [Abstract][Full Text] [Related]
10. Cytokine pattern in cystic fibrosis patients during antibiotic therapy and gene therapy using adenoviral vector.
Reix P; Bellon G; Bienvenu J; Pavirani A; Levrey-Hadden H
Eur Cytokine Netw; 2002; 13(3):324-30. PubMed ID: 12231476
[TBL] [Abstract][Full Text] [Related]
11. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
12. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.
Van Heeckeren AM; Scaria A; Schluchter MD; Ferkol TW; Wadsworth S; Davis PB
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L717-26. PubMed ID: 14514520
[TBL] [Abstract][Full Text] [Related]
13. Protection from experimental endotoxemia by a recombinant adeno-associated virus encoding interleukin 10.
Yamano S; Scott DE; Huang LY; Mikolajczyk M; Pillemer SR; Chiorini JA; Golding B; Baum BJ
J Gene Med; 2001; 3(5):450-7. PubMed ID: 11601758
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2005 Feb; 115(2):405-11. PubMed ID: 15696103
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
[TBL] [Abstract][Full Text] [Related]
16. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue.
Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B
J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497
[TBL] [Abstract][Full Text] [Related]
17. Mercaptoethylguanidine inhibits the inflammatory response in a murine model of chronic infection with Pseudomonas aeruginosa.
Wilmott RW; Kitzmiller JA; Szabó C; Southan GJ; Salzman AL
J Pharmacol Exp Ther; 2000 Jan; 292(1):88-95. PubMed ID: 10604934
[TBL] [Abstract][Full Text] [Related]
18. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia.
Greenberger MJ; Strieter RM; Kunkel SL; Danforth JM; Goodman RE; Standiford TJ
J Immunol; 1995 Jul; 155(2):722-9. PubMed ID: 7608550
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
Flotte TR
Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
